DARPA #DARPA-PA-26-09

DARPA Solicitation for Advanced Medical Technologies (RAPIID - TA3)

This opportunity is issued by the Defense Advanced Research Projects Agency (DARPA), Biological Technologies Office, seeking proposals for the RAPIID - TA3 program focused on advanced medical technologies. - Government Buyer: - Defense Advanced Research Projects Agency (DARPA) - Biological Technologies Office - Scope of Solicitation: - Research and development proposals for high technology readiness level (TRL) and medical readiness level (MRL) medical technologies - Emphasis on solutions for resuscitation and prevention of ischemia-induced dysfunction - Goal to accelerate regulatory advancement and readiness for medical use - OEMs and Vendors: - No specific OEMs or vendors are named in the solicitation - Products/Services Requested: - No specific products, part numbers, or quantities are listed - Open to advanced medical technology solutions relevant to the program's focus - Unique Requirements: - Technologies must be at high TRL/MRL and suitable for regulatory advancement - Proposals should address readiness for rapid deployment in medical settings

Description

The RAPIID program - TA3R - aims to advance high technology readiness level (TRL) and medical readiness level (MRL) capabilities through regulatory pathways. The program focuses on pushing these capabilities through the regulatory process to enhance resuscitation and prevention of ischemia-induced dysfunction. This opportunity is posted on the SAM.gov portal and is managed by the Biological Technologies Office. Proposals must be submitted by July 29, 2026.

View original listing